GCP ClinPlus Full-Service Outsourcing

GCP ClinPlus delivers full-service outsourcing (FSO) solutions for global pharmaceutical, biotech, and medtech companies conducting clinical trials in China. From regulatory strategy to clinical execution and registration, we serve as your local partner with global standards—offering speed, quality, and cost-efficiency in a single integrated model.

What is Clinical Trial Outsourcing in China?
Our full-service China Clinical Trial Outsourcing model provides comprehensive support across the entire clinical trial lifecycle—covering regulatory submissions, site activation, project management, monitoring, data management, biostatistics, medical writing, and registration filing. With deep therapeutic expertise and an experienced in-house team, GCP ClinPlus serves as an extension of your team, ensuring seamless coordination and local execution.

We have supported over 500 global clients, including industry leaders such as Johnson & Johnson, Ionis Pharmaceuticals, Abbott, MicroPort, Santen, and Bausch + Lomb. Our proven track record spans 550+ clinical studies and 220 marketing approvals from NMPA, FDA, and EMA. With our robust operational network, KOL connections, and regulatory know-how, we help you deliver high-quality trials with speed and cost-effectiveness.

Why Us?
23+ years of clinical development expertise in China.

550+ clinical trials and 210 regulatory approvals globally.

Trusted by top global sponsors including J&J, Abbott, Bausch + Lomb, Santen and others.

Full in-house capabilities across medical, regulatory, data, and operations.

Scalable teams and flexible models (FSO, hybrid, or functional outsourcing).

Proven ability to accelerate timelines and reduce cost without compromising quality.

How It Works?
Project Scoping:

We align on your study objectives, budget, and delivery needs

Team Formation:

We build a dedicated cross-functional team for your program

Turnkey Execution:

We manage end-to-end operations with transparency and accountability

Ongoing Reporting:

Regular updates, KPIs, and risk mitigation to keep your study on track

Regulatory Submission & Beyond:

We support your NDA/BLA and commercialization strategy in China

Testimonials of GCP ClinPlus
Head of Biometrics, Leading Biotech
"
GCP ClinPlus delivers exceptional expertise with genuine commitment to our projects. Their team demonstrates remarkable responsibility at every stage, consistently going above and beyond. In an industry where dedication matters, they've proven themselves an invaluable partner for our success.

"
VP of Clinical Development in China, Biotech
"
After enrollment challenges with our previous CRO threatened our study timeline, GCP ClinPlus stepped in and transformed our project. Their team rapidly accelerated patient recruitment beyond our expectations and put our critical study back on track. Their clinical expertise and swift implementation proved decisive in securing our study's success.

"
Project Manager, Pharmaceutical Company
"
GCP ClinPlus stands out for their exceptional responsiveness and customer focus. Their team consistently prioritizes our needs with prompt, thoughtful solutions to every challenge. Their combination of technical excellence and client-centered approach makes them a truly strategic partner in our development programs.

"
For more information about MRCT in China AND drug development trials, please feel free to contact us!